|
1.
|
Bartels CL and Tsongalis GJ: MicroRNAs:
novel biomarkers for human cancer. Clin Chem. 55:623–631. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Cortes-Sempere M and Ibanez de Caceres I:
microRNAs as novel epigenetic biomarkers for human cancer. Clin
Transl Oncol. 13:357–362. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Callari M, Dugo M, Musella V, et al:
Comparison of microarray platforms for measuring differential
microRNA expression in paired normal/cancer colon tissues. PLoS
One. 7:e451052012. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
D’Andrade PN and Fulmer-Smentek S: Agilent
microRNA microarray profiling system. Methods Mol Biol. 822:85–102.
2012.PubMed/NCBI
|
|
6.
|
Jang JS, Simon VA, Feddersen RM, et al:
Quantitative miRNA expression analysis using fluidigm microfluidics
dynamic arrays. BMC Genomics. 12:1442011. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Ranade AR and Weiss GJ: Methods for
microRNA microarray profiling. Methods Mol Biol. 700:145–152. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Srivastava S, Srivastava AK, Suprasanna P
and D’Souza SF: Identification and profiling of arsenic
stress-induced microRNAs in Brassica juncea. J Exp Bot.
64:303–315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Katada T, Ishiguro H, Kuwabara Y, et al:
microRNA expression profile in undifferentiated gastric cancer. Int
J Oncol. 34:537–542. 2009.PubMed/NCBI
|
|
10.
|
Li X, Zhang Y, Zhang H, et al: miRNA-223
promotes gastric cancer invasion and metastasis by targeting tumor
suppressor EPB41L3. Mol Cancer Res. 9:824–833. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Gao M, Yin H and Fei ZW: Clinical
application of microRNA in gastric cancer in Eastern Asian area.
World J Gastroenterol. 19:2019–2027. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Carvalho J, van Grieken NC, Pereira PM, et
al: Lack of microRNA-101 causes E-cadherin functional deregulation
through EZH2 up-regulation in intestinal gastric cancer. J Pathol.
228:31–44. 2012.PubMed/NCBI
|
|
13.
|
Guo J, Miao Y, Xiao B, et al: Differential
expression of microRNA species in human gastric cancer versus
non-tumorous tissues. J Gastroenterol Hepatol. 24:652–657. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Li X, Luo F, Li Q, et al: Identification
of new aberrantly expressed miRNAs in intestinal-type gastric
cancer and its clinical significance. Oncol Rep. 26:1431–1439.
2011.PubMed/NCBI
|
|
15.
|
Luo H, Zhang H, Zhang Z, et al:
Down-regulated miR-9 and miR-433 in human gastric carcinoma. J Exp
Clin Cancer Res. 28:822009. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Tsukamoto Y, Nakada C, Noguchi T, et al:
MicroRNA-375 is downregulated in gastric carcinomas and regulates
cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res.
70:2339–2349. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Ueda T, Volinia S, Okumura H, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: a microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Yao Y, Suo AL, Li ZF, et al: MicroRNA
profiling of human gastric cancer. Mol Med Rep. 2:963–970.
2009.PubMed/NCBI
|
|
19.
|
Zhang Z-Y, Wu Z-Q and Wang H-J: An
analysis of gastric cancer detection and epidemicity in high
incidental area with gastric cancer, Wuwei City, Gansu Province.
China Cancer. 10:0142009.
|
|
20.
|
Li Y-M, Shi B, Li X, Zhou W-N, Liu H and
Mi D-H: Study of the characteristics of gastric carcinoma in Wuwei
City of Gansu province. Zhonghua pu tong wai ke za zhi. 13:667–669.
2004.(In Chinese).
|
|
21.
|
Kim CH, Kim HK, Rettig RL, et al: miRNA
signature associated with outcome of gastric cancer patients
following chemotherapy. BMC Med Genomics. 4:792011. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kong D, Piao YS, Yamashita S, et al:
Inflammation-induced repression of tumor suppressor miR-7 in
gastric tumor cells. Oncogene. 31:3949–3960. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Takagi T, Iio A, Nakagawa Y, Naoe T,
Tanigawa N and Akao Y: Decreased expression of microRNA-143 and
-145 in human gastric cancers. Oncology. 77:12–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Wen D, Li S, Ji F, et al: miR-133b acts as
a tumor suppressor and negatively regulates FGFR1 in gastric
cancer. Tumour Biol. 34:793–803. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Zhao X, Dou W, He L, et al: MicroRNA-7
functions as an anti-metastatic microRNA in gastric cancer by
targeting insulin-like growth factor-1 receptor. Oncogene.
32:1363–1372. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Zhao Y, Huang J, Zhang L, et al: MiR-133b
is frequently decreased in gastric cancer and its overexpression
reduces the metastatic potential of gastric cancer cells. BMC
Cancer. 14:342014. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Xia J, Wu Z, Yu C, et al: miR-124 inhibits
cell proliferation in gastric cancer through down-regulation of
SPHK1. J Pathol. 227:470–480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Kogo R, Mimori K, Tanaka F, Komune S and
Mori M: Clinical significance of miR-146a in gastric cancer cases.
Clin Cancer Res. 17:4277–4284. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Yao Q, Cao Z, Tu C, Zhao Y, Liu H and
Zhang S: MicroRNA-146a acts as a metastasis suppressor in gastric
cancer by targeting WASF2. Cancer Lett. 335:219–224. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Hou Z, Xie L, Yu L, Qian X and Liu B:
MicroRNA-146a is down-regulated in gastric cancer and regulates
cell proliferation and apoptosis. Med Oncol. 29:886–892. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Hou Z, Yin H, Chen C, et al: microRNA-146a
targets the L1 cell adhesion molecule and suppresses the metastatic
potential of gastric cancer. Mol Med Rep. 6:501–506. 2012.
|
|
32.
|
Crone SG, Jacobsen A, Federspiel B, et al:
microRNA-146a inhibits G protein-coupled receptor-mediated
activation of NF-kappaB by targeting CARD10 and COPS8 in gastric
cancer. Mol Cancer. 11:712012. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Xiao B, Zhu ED, Li N, et al: Increased
miR-146a in gastric cancer directly targets SMAD4 and is involved
in modulating cell proliferation and apoptosis. Oncol Rep.
27:559–566. 2012.PubMed/NCBI
|
|
34.
|
Kim BH, Hong SW, Kim A, Choi SH and Yoon
SO: Prognostic implications for high expression of oncogenic
microRNAs in advanced gastric carcinoma. J Surg Oncol. 107:505–510.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Liu L, Chen Q, Lai R, et al: Elevated
expression of mature miR-21 and miR-155 in cancerous gastric
tissues from Chinese patients with gastric cancer. J Biomed Res.
24:187–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Li CL, Nie H, Wang M, et al: microRNA-155
is downregulated in gastric cancer cells and involved in cell
metastasis. Oncol Rep. 27:1960–1966. 2012.PubMed/NCBI
|
|
37.
|
Xu Y, Zhao F, Wang Z, et al: MicroRNA-335
acts as a metastasis suppressor in gastric cancer by targeting
Bcl-w and specificity protein 1. Oncogene. 31:1398–1407. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Yan Z, Xiong Y, Xu W, et al:
Identification of hsa-miR-335 as a prognostic signature in gastric
cancer. PLoS One. 7:e400372012. View Article : Google Scholar : PubMed/NCBI
|
